Emmaus Life Sciences, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Baker Tilly, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 USD | -1.53% | 0.00% | -0.10% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.10% | 6.39M | |
+21.25% | 47.9B | |
+46.56% | 41.42B | |
-2.33% | 40.7B | |
-6.20% | 28.92B | |
+10.63% | 25.55B | |
-21.40% | 19.27B | |
-2.01% | 12.15B | |
+31.05% | 12.14B | |
-0.80% | 11.99B |
- Stock Market
- Equities
- EMMA Stock
- News Emmaus Life Sciences, Inc.
- Emmaus Life Sciences, Inc. Auditor Raises 'Going Concern' Doubt